|Medtronic EVP & President Hooman Hakami to Speak at Oppenheimer Healthcare Conference|
DUBLIN - March 16, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Oppenheimer 27th Annual Healthcare Conference on Tuesday, March 21, 2017, in New York City.
Hooman Hakami, executive vice president and group president of Medtronic's Diabetes Group, will answer questions about the company beginning at 8:35 a.m. EDT (7:35 a.m. CDT).
A live audio webcast of the presentation will be available on March 21, 2017, by clicking on the Investor Events link at http://investorrelations.medtronic.com. An archive of the session will be available on the same webpage later in the day.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.